Earnings Outlook For Bionano Genomics
Portfolio Pulse from Benzinga Insights
Bionano Genomics (NASDAQ:BNGO) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $-0.87. The company's past earnings performance shows a trend of not meeting EPS estimates, leading to varying stock price reactions. Shares are currently trading at $1.25, reflecting a 90.84% decline over the last year. Investors are looking for positive guidance for the next quarter.
March 04, 2024 | 6:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bionano Genomics is expected to report an EPS of $-0.87 for the upcoming quarter. Historical performance shows a trend of not meeting EPS estimates, affecting stock prices. Currently, shares are significantly down, indicating investor concern.
Given Bionano Genomics' history of not meeting EPS estimates and the significant decline in share price over the past year, the upcoming earnings report is critical. However, the consistent underperformance in EPS and the negative trend in stock price suggest a likely negative short-term impact on BNGO's stock price, especially if the company fails to meet or exceed the EPS estimate again or provides weak guidance for the future.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100